What is AbbVie's EPS (diluted)?

AbbVie (ABBV) reported EPS (diluted) of $0.39 in Q1 2026.

How has AbbVie's EPS (diluted) changed year-over-year?

AbbVie's EPS (diluted) decreased by 45.8% year-over-year, from $0.72 to $0.39.

What is the long-term trend for AbbVie's EPS (diluted)?

Over 4 years (2021 to 2025), AbbVie's EPS (diluted) has grown at a -22.2% compound annual growth rate (CAGR), from $6.45 to $2.36.

What does EPS (diluted) mean?

Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

AbbVie ABBV EPS (Diluted)

EPS (Diluted) at other companies

Eli LillyLLY

$8.26+170%

PfizerPFE

$0.47-9.6%

Johnson & JohnsonJNJ

$2.14-52.9%

AmgenAMGN

$3.34+4.4%

The Cooper Companies, Inc.COO

-$0.40-191%

Vertex PharmaceuticalsVRTX

$4.02+61.4%

Other financials

Income statement

See full

Revenue$15.0B+12.4%

Gross profit$10.8B+15.4%

Operating income$4.0B+6.9%

Net income$695.0M-46.0%

Balance sheet

See full

Cash & equivalents$9.4B+81.5%

Total debt$62.4B+1.8%

Total equity-$6.7B-569%

Total assets$136.46B+0.2%

Cash flow

See full

Operating cash flow$3.8B+134%

CapEx$265.0M+12.8%

Free cash flow$3.6B+155%

Valuation

See full

Market cap$429.58B+31.2%

P/E118.2×+40.2×

P/S6.8×+1.1×

Profitability

See full

Gross margin70.7%0.0pp

Operating margin24.4%—

Net margin5.8%-1.5pp

FCF margin31.8%+5.0pp

Returns & leverage

See full

Return on equity89%+32.7pp

Debt / equity46.6×+38.6×

Current ratio0.8×0.0×

Where this comes from

Reported directly by AbbVie in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: AbbVie’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbbVie's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AbbVie's EPS (diluted)?: AbbVie (ABBV) reported EPS (diluted) of $0.39 in Q1 2026.
How has AbbVie's EPS (diluted) changed year-over-year?: AbbVie's EPS (diluted) decreased by 45.8% year-over-year, from $0.72 to $0.39.
What is the long-term trend for AbbVie's EPS (diluted)?: Over 4 years (2021 to 2025), AbbVie's EPS (diluted) has grown at a -22.2% compound annual growth rate (CAGR), from $6.45 to $2.36.
What does EPS (diluted) mean?: Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.